Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Globe Life Inc ha un obiettivo di prezzo di consenso pari a $148.67, stabilito in base alle ultime valutazioni degli analisti di 15. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, Morgan Stanley y Morgan Stanley il octubre 8, 2025, agosto 18, 2025 y agosto 5, 2025. Con un obiettivo di prezzo medio di $169.67 tra le Wells Fargo, Morgan Stanley y Morgan Stanley, c'è un implicito 24.07% upside per Globe Life Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
Morgan Stanley
BMO Capital
Keefe, Bruyette & Woods
Morgan Stanley
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Globe Life
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/08/2025 | 25.78% | Wells Fargo | $150 → $172 | Maintains | Overweight | |||
08/18/2025 | 25.05% | Morgan Stanley | $166 → $171 | Maintains | Overweight | |||
08/05/2025 | 21.39% | Morgan Stanley | $135 → $166 | Upgrade | Equal-Weight → Overweight | |||
07/30/2025 | 8.96% | BMO Capital | $114 → $149 | Maintains | Market Perform | |||
07/29/2025 | 17% | Keefe, Bruyette & Woods | $155 → $160 | Maintains | Outperform | |||
07/28/2025 | 13.35% | Keefe, Bruyette & Woods | $145 → $155 | Maintains | Outperform | |||
07/25/2025 | 9.69% | Wells Fargo | $144 → $150 | Maintains | Overweight | |||
07/25/2025 | -1.28% | Morgan Stanley | $127 → $135 | Maintains | Equal-Weight | |||
07/15/2025 | 9.69% | Truist Securities | → $150 | Initiates | → Buy | |||
07/14/2025 | -7.13% | Morgan Stanley | $125 → $127 | Maintains | Equal-Weight | |||
07/10/2025 | 5.3% | Wells Fargo | $139 → $144 | Maintains | Overweight | |||
07/08/2025 | 17% | JP Morgan | $145 → $160 | Maintains | Overweight | |||
05/19/2025 | -8.59% | Morgan Stanley | $117 → $125 | Maintains | Equal-Weight | |||
05/06/2025 | 1.65% | Wells Fargo | $140 → $139 | Maintains | Overweight | |||
05/02/2025 | 7.5% | Piper Sandler | $152 → $147 | Maintains | Overweight | |||
04/10/2025 | 2.38% | Wells Fargo | $141 → $140 | Maintains | Overweight | |||
04/10/2025 | -14.44% | Morgan Stanley | $126 → $117 | Maintains | Equal-Weight | |||
04/02/2025 | 11.15% | Piper Sandler | $140 → $152 | Maintains | Overweight | |||
04/02/2025 | 6.03% | JP Morgan | $136 → $145 | Maintains | Overweight | |||
02/28/2025 | -7.86% | Morgan Stanley | $125 → $126 | Maintains | Equal-Weight | |||
02/19/2025 | 3.11% | Wells Fargo | $126 → $141 | Maintains | Overweight | |||
02/12/2025 | 6.03% | Keefe, Bruyette & Woods | $137 → $145 | Maintains | Outperform | |||
02/11/2025 | -8.59% | Morgan Stanley | $123 → $125 | Maintains | Equal-Weight | |||
01/23/2025 | -16.64% | BMO Capital | → $114 | Initiates | → Market Perform | |||
01/10/2025 | 0.18% | Keefe, Bruyette & Woods | $135 → $137 | Maintains | Outperform | |||
01/08/2025 | 4.57% | Evercore ISI Group | $132 → $143 | Upgrade | In-Line → Outperform | |||
12/10/2024 | -16.64% | Jefferies | $107 → $114 | Maintains | Hold | |||
10/29/2024 | -8.59% | Keefe, Bruyette & Woods | $120 → $125 | Maintains | Outperform | |||
10/25/2024 | -4.94% | Piper Sandler | $118 → $130 | Maintains | Overweight | |||
10/25/2024 | -23.22% | Truist Securities | $90 → $105 | Maintains | Hold | |||
10/24/2024 | -12.25% | Morgan Stanley | $110 → $120 | Maintains | Equal-Weight | |||
10/15/2024 | 37.48% | Raymond James | $160 → $188 | Maintains | Strong Buy | |||
10/10/2024 | -14.44% | Wells Fargo | $108 → $117 | Maintains | Overweight | |||
10/09/2024 | 9.69% | TD Cowen | → $150 | Initiates | → Buy | |||
10/02/2024 | -13.71% | Piper Sandler | $106 → $118 | Maintains | Overweight | |||
08/19/2024 | -39.31% | Morgan Stanley | $66 → $83 | Maintains | Equal-Weight | |||
07/31/2024 | -13.71% | Keefe, Bruyette & Woods | $110 → $118 | Reiterates | Outperform → Outperform | |||
07/26/2024 | -22.49% | Piper Sandler | $105 → $106 | Maintains | Overweight | |||
07/26/2024 | -34.19% | Truist Securities | $80 → $90 | Maintains | Hold | |||
07/26/2024 | -21.02% | Wells Fargo | $105 → $108 | Maintains | Overweight | |||
07/10/2024 | -52.47% | Morgan Stanley | $62 → $65 | Maintains | Equal-Weight | |||
06/28/2024 | -35.65% | Jefferies | $85 → $88 | Maintains | Hold | |||
06/28/2024 | -23.22% | Piper Sandler | $110 → $105 | Maintains | Overweight | |||
06/26/2024 | -37.11% | Evercore ISI Group | $83 → $86 | Maintains | In-Line | |||
05/21/2024 | — | Raymond James | — | Reiterates | → Strong Buy | |||
04/24/2024 | -21.02% | Wells Fargo | $132 → $108 | Maintains | Overweight | |||
04/24/2024 | -19.56% | Keefe, Bruyette & Woods | $130 → $110 | Upgrade | Market Perform → Outperform | |||
04/24/2024 | -19.56% | Piper Sandler | $130 → $110 | Maintains | Overweight | |||
04/24/2024 | -41.5% | Truist Securities | $125 → $80 | Maintains | Hold | |||
04/12/2024 | -8.59% | Truist Securities | $125 → $125 | Maintains | Hold | |||
04/12/2024 | -45.16% | Evercore ISI Group | $125 → $75 | Maintains | In-Line | |||
04/11/2024 | -3.47% | Wells Fargo | $146 → $132 | Maintains | Overweight | |||
04/10/2024 | -4.94% | Keefe, Bruyette & Woods | $135 → $130 | Maintains | Market Perform | |||
04/05/2024 | -4.94% | Piper Sandler | $143 → $130 | Maintains | Overweight | |||
03/14/2024 | -8.59% | Evercore ISI Group | $138 → $125 | Maintains | In-Line | |||
02/09/2024 | -8.59% | Truist Securities | $115 → $125 | Maintains | Hold | |||
02/08/2024 | -0.55% | JP Morgan | $133 → $136 | Maintains | Overweight | |||
11/15/2023 | -3.47% | Morgan Stanley | $131 → $132 | Maintains | Equal-Weight | |||
10/31/2023 | 0.18% | Wells Fargo | $122 → $137 | Upgrade | Equal-Weight → Overweight | |||
10/23/2023 | 17% | Raymond James | $138 → $160 | Maintains | Strong Buy | |||
10/06/2023 | -3.47% | JP Morgan | $131 → $132 | Maintains | Overweight | |||
09/14/2023 | -13.71% | Jefferies | $115 → $118 | Maintains | Hold | |||
08/18/2023 | -4.2% | Morgan Stanley | → $131 | Upgrade | Underweight → Equal-Weight | |||
08/02/2023 | -4.2% | Morgan Stanley | $131 → $131 | Reiterates | Underweight → Underweight | |||
07/27/2023 | -4.2% | Morgan Stanley | $130 → $131 | Maintains | Underweight | |||
07/17/2023 | -10.79% | Wells Fargo | $121 → $122 | Maintains | Equal-Weight | |||
06/09/2023 | -7.13% | Keefe, Bruyette & Woods | → $127 | Reiterates | → Market Perform | |||
05/15/2023 | -11.52% | Wells Fargo | $120 → $121 | Maintains | Equal-Weight | |||
05/05/2023 | -15.9% | Truist Securities | $125 → $115 | Maintains | Hold | |||
05/05/2023 | -4.94% | Piper Sandler | $135 → $130 | Maintains | Overweight | |||
05/04/2023 | -4.94% | Morgan Stanley | $129 → $130 | Maintains | Underweight | |||
04/25/2023 | -12.25% | Wells Fargo | → $120 | Initiates | → Equal-Weight | |||
04/12/2023 | -5.67% | Morgan Stanley | $133 → $129 | Maintains | Underweight | |||
03/14/2023 | 0.91% | Raymond James | $141 → $138 | Maintains | Strong Buy | |||
02/24/2023 | -2.74% | Morgan Stanley | $132 → $133 | Maintains | Underweight | |||
02/15/2023 | 3.11% | Raymond James | $138 → $141 | Maintains | Strong Buy | |||
02/03/2023 | -8.59% | Truist Securities | $112 → $125 | Maintains | Hold | |||
01/10/2023 | -3.47% | Morgan Stanley | $115 → $132 | Maintains | Underweight | |||
01/06/2023 | -7.86% | JP Morgan | $112 → $126 | Maintains | Overweight | |||
12/20/2022 | -4.94% | Piper Sandler | $127 → $130 | Maintains | Overweight | |||
12/19/2022 | 2.38% | Credit Suisse | $130 → $140 | Maintains | Outperform | |||
11/17/2022 | -15.9% | Morgan Stanley | $112 → $115 | Maintains | Underweight | |||
10/28/2022 | -18.1% | Truist Securities | $100 → $112 | Maintains | Hold | |||
10/28/2022 | -16.64% | Evercore ISI Group | $115 → $114 | Downgrade | Outperform → In-Line | |||
10/27/2022 | -18.1% | Morgan Stanley | $110 → $112 | Maintains | Underweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Globe Life (GL)?
El último precio objetivo de Globe Life (NYSE:GL) fue comunicado por Wells Fargo el octubre 8, 2025. La firma de analistas fijó un precio objetivo para $172.00 que espera GL a rise dentro de 12 meses (un posible 25.78% upside). 33 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Globe Life (GL)?
La última calificación de analistas para Globe Life (NYSE:GL) fue proporcionada por Wells Fargo, y Globe Life mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Globe Life (GL)?
La última revisión al alza de Globe Life Inc se produjo en agosto 5, 2025, cuando Morgan Stanley elevó su precio objetivo a $166. Morgan Stanley anteriormente tenía an equal-weight para Globe Life Inc.
¿Cuándo fue la última revisión a la baja de Globe Life (GL)?
La última revisión a la baja de Globe Life Inc se produjo en octubre 28, 2022, cuando Evercore ISI Group cambió su precio objetivo de $115 a $114 para Globe Life Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Globe Life (GL)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Globe Life, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Globe Life se registró el octubre 8, 2025, por lo que la próxima calificación estará disponible en torno al octubre 8, 2026.
¿Es correcta la calificación de los analistas sobre Globe Life (GL)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Globe Life (GL) fue un mantuvo con un precio objetivo de $150.00 a $172.00. El precio actual al que cotiza Globe Life (GL) es de $136.75, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.